Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary diffuse large cell lymphoma of the mandible.
Rosado MF, Morgensztern D, Peleg M, Lossos IS. Rosado MF, et al. Among authors: lossos is. Leuk Lymphoma. 2004 May;45(5):1049-53. doi: 10.1080/10428190310001625737. Leuk Lymphoma. 2004. PMID: 15291366 Review.
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.
Ramos JC, Ruiz P Jr, Ratner L, Reis IM, Brites C, Pedroso C, Byrne GE Jr, Toomey NL, Andela V, Harhaj EW, Lossos IS, Harrington WJ Jr. Ramos JC, et al. Among authors: lossos is. Blood. 2007 Apr 1;109(7):3060-8. doi: 10.1182/blood-2006-07-036368. Blood. 2007. PMID: 17138822 Free PMC article.
Extranodal marginal zone lymphoma of the ocular adnexa.
Stefanovic A, Lossos IS. Stefanovic A, et al. Among authors: lossos is. Blood. 2009 Jul 16;114(3):501-10. doi: 10.1182/blood-2008-12-195453. Epub 2009 Apr 16. Blood. 2009. PMID: 19372259 Free PMC article. Review.
Primary bone lymphoma--the University of Miami experience.
Alencar A, Pitcher D, Byrne G, Lossos IS. Alencar A, et al. Among authors: lossos is. Leuk Lymphoma. 2010 Jan;51(1):39-49. doi: 10.3109/10428190903308007. Leuk Lymphoma. 2010. PMID: 19860629 Review.
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma.
Lossos IS, Hosein PJ, Morgensztern D, Coleman F, Escalón MP, Byrne GE Jr, Rosenblatt JD, Walker GR. Lossos IS, et al. Leuk Lymphoma. 2010 Mar;51(3):406-14. doi: 10.3109/10428190903518345. Leuk Lymphoma. 2010. PMID: 20038221 Clinical Trial.
338 results